{
    "clinical_study": {
        "@rank": "156400", 
        "arm_group": [
            {
                "arm_group_label": "Folic Acid, vit B6 and B12", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated\n      with extracellular matrix changes. Many studies demonstrated that high levels of this\n      aminoacid in diabetic patients increases significantly the risk of the development of this\n      pathology. This study has been undertaken to investigate the role of homocysteine and its\n      cofactors (folic acid, vitamin B6 and B12) during the progression of the diabetic\n      retinopathy."
        }, 
        "brief_title": "Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy", 
        "condition": [
            "Non Proliferative Diabetic Retinopathy", 
            "Proliferative Diabetic Retinopathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetic Retinopathy", 
                "Retinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diabetic patients with proliferative and non proliferative retinopathy\n\n        Exclusion Criteria:\n\n          -  Patients with chronic liver disease Patients with kidney disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01921192", 
            "org_study_id": "1/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Folic Acid, vit B6 and B12", 
                "intervention_name": "Folic Acid, vit B6 and B12", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Folic Acid", 
                "Vitamin B Complex", 
                "Hematinics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Catania", 
                    "country": "Italy", 
                    "zip": "95125"
                }, 
                "name": "University of Catania, Cannizzaro Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "other_outcome": [
            {
                "measure": "vitamin B6", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "vitamin B12", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "overall_contact": {
            "email": "malaguar@unict.it", 
            "last_name": "Mariano Malaguarnera, A.P.", 
            "phone": "+39(0)957262008"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "homocysteine", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01921192"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Catania", 
            "investigator_full_name": "Mariano Malaguarnera", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "folic acid", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "University of Catania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Catania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}